Filter News
Area of Research
- (-) Materials (21)
- Advanced Manufacturing (2)
- Biology and Environment (13)
- Clean Energy (16)
- Computational Engineering (1)
- Computer Science (3)
- Electricity and Smart Grid (1)
- Functional Materials for Energy (1)
- Fusion and Fission (1)
- Isotopes (14)
- Materials for Computing (3)
- National Security (19)
- Neutron Science (10)
- Nuclear Science and Technology (3)
- Quantum information Science (2)
- Supercomputing (36)
News Topics
- (-) Cybersecurity (3)
- (-) Isotopes (5)
- (-) Machine Learning (3)
- (-) Quantum Science (10)
- (-) Summit (1)
- 3-D Printing/Advanced Manufacturing (13)
- Advanced Reactors (2)
- Artificial Intelligence (5)
- Bioenergy (9)
- Biology (4)
- Biomedical (3)
- Buildings (3)
- Chemical Sciences (22)
- Climate Change (5)
- Composites (3)
- Computer Science (8)
- Coronavirus (2)
- Critical Materials (8)
- Decarbonization (5)
- Energy Storage (21)
- Environment (9)
- Exascale Computing (1)
- Frontier (3)
- Fusion (3)
- Grid (3)
- High-Performance Computing (3)
- Irradiation (1)
- ITER (1)
- Materials (46)
- Materials Science (43)
- Microscopy (17)
- Molten Salt (2)
- Nanotechnology (25)
- National Security (3)
- Net Zero (1)
- Neutron Science (21)
- Nuclear Energy (5)
- Partnerships (9)
- Physics (20)
- Polymers (8)
- Quantum Computing (2)
- Renewable Energy (1)
- Security (1)
- Simulation (1)
- Sustainable Energy (8)
- Transformational Challenge Reactor (1)
- Transportation (5)
Media Contacts
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.